BIM
ATRS

BlackRock Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-556,754
Closed -$484K – 4162
2016
Q1 		$484K Buy
556,754
+15,333
+3% +$14.8K ﹤0.01% 2914
2015
Q4 		$655K Buy
541,421
+1,749
+0.3% +$2.43K ﹤0.01% 2874
2015
Q3 		$917K Sell
539,672
-10,584
-2% -$20.7K ﹤0.01% 2661
2015
Q2 		$1.15M Buy
550,256
+209,414
+61% +$508K ﹤0.01% 2667
2015
Q1 		$924K Buy
340,842
+1,307
+0.4% +$3.32K ﹤0.01% 2576
2014
Q4 		$873K Sell
339,535
-4,089
-1% -$9.19K ﹤0.01% 2633
2014
Q3 		$629K Buy
343,624
+6,723
+2% +$14.7K ﹤0.01% 2837
2014
Q2 		$900K Buy
336,901
+24,665
+8% +$74.2K ﹤0.01% 2676
2014
Q1 		$1.09M Buy
312,236
+3,029
+1% +$13.4K ﹤0.01% 2450
2013
Q4 		$1.38M Sell
309,207
-10,125
-3% -$41.3K ﹤0.01% 2277
2013
Q3 		$1.3M Buy
319,332
+20,209
+7% +$88.3K ﹤0.01% 2259
2013
Q2 		$1.24M Buy
+299,123
New +$1.16M ﹤0.01% 2203

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLP
Pleasant Lake Partners Rincon, Puerto Rico $7.91M AUM 5.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock Investment Management's ATRS Position: Q2 2016 in Review

BlackRock Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2016, closing a stake of 556,754 shares — an estimated $484K sold.

BlackRock Investment Management first reported a position in ATRS in Q2 2013 and held it in 12 quarters. The position peaked at $1.38M in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q2 2016.

  • BlackRock Investment Management reported no remaining Antares Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 556,754 Antares Pharma, Inc. shares in Q2 2016, an estimated $484K.
  • BlackRock Investment Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's Antares Pharma, Inc. position peaked at $1.38M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.